Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (111-120 of 401) with videos related to

Pageof 41
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stentingJavaid Iqbal, Wael Sumaya, Victoria Tatman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
The Cochrane Database of Systematic Reviews|January 24, 2024
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysisSamer Al Said, Klaus Kaier, Wael Sumaya, et al.
European Heart Journal|February 2, 2018
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudyWael Sumaya, Lars Wallentin, Stefan K James, et al.
Platelets|June 14, 2006
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapySimon M G Smith, Heather M Judge, Gary Peters, et al.
JTCVS Open|October 9, 2023
Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass graftingKambiz Hassan, Stephan Geidel, Vipin Zamvar, et al.
Journal of Thoracic Disease|September 8, 2022
Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery-a systematic reviewMarijana Matejic-Spasic, Kambiz Hassan, Matthias Thielmann, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 2, 2012
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trialHany Siha, Debraj Das, Yuling Fu, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Thrombosis and Haemostasis|September 9, 2016
Studies of the interaction of ticagrelor with the P2Y<sub>13</sub> receptor and with P2Y<sub>13</sub>-dependent pro-platelet formation by human megakaryocytesAnna Björquist, Christian A Di Buduo, Eti A Femia, et al.
Pageof 41

Showing results (111-120 of 401) with videos related to

Sort By:
Pageof 41
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stentingJavaid Iqbal, Wael Sumaya, Victoria Tatman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
The Cochrane Database of Systematic Reviews|January 24, 2024
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysisSamer Al Said, Klaus Kaier, Wael Sumaya, et al.
European Heart Journal|February 2, 2018
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudyWael Sumaya, Lars Wallentin, Stefan K James, et al.
Platelets|June 14, 2006
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapySimon M G Smith, Heather M Judge, Gary Peters, et al.
JTCVS Open|October 9, 2023
Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass graftingKambiz Hassan, Stephan Geidel, Vipin Zamvar, et al.
Journal of Thoracic Disease|September 8, 2022
Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery-a systematic reviewMarijana Matejic-Spasic, Kambiz Hassan, Matthias Thielmann, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 2, 2012
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trialHany Siha, Debraj Das, Yuling Fu, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Thrombosis and Haemostasis|September 9, 2016
Studies of the interaction of ticagrelor with the P2Y<sub>13</sub> receptor and with P2Y<sub>13</sub>-dependent pro-platelet formation by human megakaryocytesAnna Björquist, Christian A Di Buduo, Eti A Femia, et al.
Pageof 41